Freund : FACTSHEET FY201702 3Q(PDF)

PL

（￥thousand）	FY2/13							FY2/14
Q1	Q2	1H	Q3	Q4	2H	Full-Year	Q1	Q2	1H	Q3	Q4	2H	Full-Year
Net sales Cost of sales Gross profit Selling, general and administrative expenses Operating income Non-operating income Foreign exchange gains Non-operating expenses Ordinary income Extraordinary income Extraordinary losses Income (loss) before income taxes and minority interests Total income taxes Profit (loss) attributable to non-controlling interests Profit (loss) attributable to owners of parent EBITDA EBITDA=Operating income＋Technical support fee＋Interest expenses＋Depreciation	4,728,509 3,350,143 1,378,365 884,268 494,096 79,834 - 3,386 570,545 77 996 569,625 227,935 9,124 332,565 552,385	3,950,865 2,654,731 1,296,133 896,479 399,653 24,457 - 550 423,560 4,611 301,398 126,773 111,426 (22,140) 37,487 461,675	8,679,375 6,004,875 2,674,499 1,780,748 893,750 104,292 - 3,937 994,105 4,688 302,395 696,399 339,362 (13,015) 370,052 1,014,060	3,886,900 2,674,687 1,212,213 864,528 347,684 15,816 4,228 729 362,772 - (1,604) 364,377 170,962 (1,974) 195,389 409,966	3,830,664 2,634,235 1,196,428 967,708 228,720 31,583 23,312 (1,108) 261,412 17,084 1,507 276,989 74,111 2,963 199,914 293,372	7,717,564 5,308,922 2,408,641 1,832,236 576,405 47,400 27,541 (379) 624,184 17,084 (97) 641,366 245,073 989 395,303 703,338	16,396,939 11,313,798 5,083,141 3,612,985 1,470,155 151,692 27,541 3,558 1,618,290 21,773 302,297 1,337,765 584,435 (12,026) 765,356 1,717,398	4,656,831 3,107,223 1,549,608 987,123 562,485 22,394 13,999 3,259 581,619 1,756 43 583,332 272,948 1,337 309,047 634,788	4,224,845 2,963,231 1,261,614 980,217 281,396 11,259 (6,982) 974 291,681 2,367 404 293,644 128,793 3,030 161,820 360,799	8,881,677 6,070,454 2,811,222 1,967,341 843,881 33,653 7,017 4,234 873,301 4,124 448 876,976 401,741 4,368 470,867 995,587	3,545,402 2,468,833 1,076,569 920,131 156,437 18,419 9,555 1,867 172,988 524 22,538 150,975 78,904 3,654 68,417 235,865	5,189,203 3,838,309 1,350,894 1,064,667 286,227 8,774 (3,892) (637) 295,638 17 163 295,492 39,762 7,172 248,557 378,816	8,734,606 6,307,142 2,427,464 1,984,799 442,664 27,193 5,662 1,230 468,627 541 22,701 446,468 118,666 10,826 316,974 614,681	17,616,284 12,377,597 5,238,686 3,952,140 1,286,546 60,847 12,679 5,464 1,341,929 4,665 23,149 1,323,445 520,408 15,194 787,841 1,610,268
Foreign exchange rate (Average exchange rate of cumulative period) /US$	79.36	79.77	79.77	79.39	79.80	79.80	79.80	92.46	95.73	95.73	96.83	97.73	97.73	97.73
Capital investment (including acquisition of leased assets) Depreciation R&D expenses	16,785 54,407 97,595	58,281 57,349 106,411	75,066 111,757 204,006	75,901 58,617 110,818	71,313 62,310 120,329	147,214 120,928 231,147	222,281 232,685 435,154	274,679 69,411 103,829	9,333 72,527 123,167	284,012 141,938 226,997	108,855 74,276 120,644	84,571 87,578 116,455	193,427 161,855 237,099	477,440 303,794 464,097
Composition ratio (%) COGS ratio Gross profit margin SG&A expenses ratio Operating income margin Ordinary income margin Net income margin R&D expenses ratio	70.8% 29.2% 18.7% 10.4% 12.1% 7.0% 2.1%	67.2% 32.8% 22.7% 10.1% 10.7% 0.9% 2.7%	69.2% 30.8% 20.5% 10.3% 11.5% 4.3% 2.4%	68.8% 31.2% 22.2% 8.9% 9.3% 5.0% 2.9%	68.8% 31.2% 25.3% 6.0% 6.8% 5.2% 3.1%	68.8% 31.2% 23.7% 7.5% 8.1% 5.1% 3.0%	69.0% 31.0% 22.0% 9.0% 9.9% 4.7% 2.7%	66.7% 33.3% 21.2% 12.1% 12.5% 6.6% 2.2%	70.1% 29.9% 23.2% 6.7% 6.9% 3.8% 2.9%	68.3% 31.7% 22.2% 9.5% 9.8% 5.3% 2.6%	69.6% 30.4% 26.0% 4.4% 4.9% 1.9% 3.4%	74.0% 26.0% 20.5% 5.5% 5.7% 4.8% 2.2%	72.2% 27.8% 22.7% 5.1% 5.4% 3.6% 2.7%	70.3% 29.7% 22.4% 7.3% 7.6% 4.5% 2.6%
Year-over-year basis (%) Net sales Cost of sales Gross profit Selling, general and administrative expenses Operating income	45.2% 47.7% 39.5% 3.5% 270.0%	5.5% 3.7% 9.3% 0.8% 34.8%	24.0% 24.4% 23.0% 2.1% 107.8%	2.0% 5.0% -4.2% -1.4% -10.4%	-13.4% -18.9% 2.0% 4.5% -7.5%	-6.3% -8.4% -1.2% 1.6% -9.2%	7.6% 6.5% 10.2% 1.9% 38.0%	-1.5% -7.3% 12.4% 11.6% 13.8%	6.9% 11.6% -2.7% 9.3% -29.6%	2.3% 1.1% 5.1% 10.5% -5.6%	-8.8% -7.7% -11.2% 6.4% -55.0%	35.5% 45.7% 12.9% 10.0% 25.1%	13.2% 18.8% 0.8% 8.3% -23.2%	7.4% 9.4% 3.1% 9.4% -12.5%

By business segment

（￥thousand）	FY2/13							FY2/14
Q1	Q2	1H	Q3	Q4	2H	Full-Year	Q1	Q2	1H	Q3	Q4	2H	Full-Year
Net sales Machinery Business Segment Pharmaceutical Products Industrial Products Chemicals Business Segment Pharmaceutical Excipients Food Preservatives Dietary Supplement Products	4,728,509	3,950,865	8,679,375	3,886,900	3,830,664	7,717,564	16,396,939	4,656,831	4,224,845	8,881,677	3,545,402	5,189,203	8,734,606	17,616,284
	3,240,641	2,376,530	5,617,172	2,078,342	2,219,310	4,297,652	9,914,824	3,048,680	2,684,594	5,733,274	1,933,878	3,337,480	5,271,358	11,004,633
	2,714,112	1,959,180	4,673,292	1,800,466	1,774,468	3,574,935	8,248,227	2,801,399	2,219,521	5,020,921	1,756,188	2,960,484	4,716,673	9,737,594
	526,528	417,350	943,879	277,875	444,841	722,717	1,666,596	247,280	465,072	712,353	177,689	376,995	554,685	1,267,038
	1,487,868	1,574,334	3,062,203	1,808,558	1,611,354	3,419,912	6,482,115	1,608,151	1,540,251	3,148,402	1,611,524	1,851,723	3,463,247	6,611,650
	450,933	547,157	998,090	572,679	470,174	1,042,854	2,040,945	508,181	470,078	978,260	448,385	546,124	994,509	1,972,769
	487,953	435,085	923,039	501,043	465,086	966,129	1,889,169	473,884	428,041	901,926	513,294	500,018	1,013,312	1,915,239
	548,981	592,091	1,141,072	734,835	676,092	1,410,928	2,552,000	626,084	642,130	1,268,215	649,844	805,581	1,455,425	2,723,641
Segment income	494,096	399,653	893,750	347,684	228,720	576,405	1,470,155	562,485	281,396	843,881	156,437	286,227	442,664	1,286,546
Machinery Business Segment	419,473	309,062	728,536	234,079	209,467	443,546	1,172,082	496,861	261,949	758,810	166,539	316,969	483,509	1,242,320
Chemicals Business Segment	142,875	156,795	299,671	180,328	85,228	265,556	565,227	162,804	94,221	257,025	67,631	54,837	122,469	379,495
Adjustments	(68,252)	(66,204)	(134,456)	(66,722)	(65,974)	(132,697)	(267,154)	(97,180)	(74,774)	(171,955)	(77,733)	(85,580)	(163,313)	(335,268)
Composition ratio (%) Machinery Business Segment Pharmaceutical Products Industrial Products Chemicals Business Segment Pharmaceutical Excipients Food Preservatives Dietary Supplement Products	68.5%	60.2%	64.7%	53.5%	57.9%	55.7%	60.5%	65.5%	63.5%	64.6%	54.5%	64.3%	60.4%	62.5%
	83.8%	82.4%	83.2%	86.6%	80.0%	83.2%	83.2%	91.9%	82.7%	87.6%	90.8%	88.7%	89.5%	88.5%
	16.2%	17.6%	16.8%	13.4%	20.0%	16.8%	16.8%	8.1%	17.3%	12.4%	9.2%	11.3%	10.5%	11.5%
	31.5%	39.8%	35.3%	46.5%	42.1%	44.3%	39.5%	34.5%	36.5%	35.4%	45.5%	35.7%	39.6%	37.5%
	30.3%	34.8%	32.6%	31.7%	29.2%	30.5%	31.5%	31.6%	30.5%	31.1%	27.8%	29.5%	28.7%	29.8%
	32.8%	27.6%	30.1%	27.7%	28.9%	28.3%	29.1%	29.5%	27.8%	28.6%	31.9%	27.0%	29.3%	29.0%
	36.9%	37.6%	37.3%	40.6%	42.0%	41.3%	39.4%	38.9%	41.7%	40.3%	40.3%	43.5%	42.0%	41.2%
Segment income margin (%) Machinery Business Segment Chemicals Business Segment Year-over-year basis (%) Net sales Machinery Business Segment Chemicals Business Segment Segment income Machinery Business Segment Chemicals Business Segment	12.9%	13.0%	13.0%	11.3%	9.4%	10.3%	11.8%	16.3%	9.8%	13.2%	8.6%	9.5%	9.2%	11.3%
	9.6%	10.0%	9.8%	10.0%	5.3%	7.8%	8.7%	10.1%	6.1%	8.2%	4.2%	3.0%	3.5%	5.7%
	45.2%	5.5%	24.0%	2.0%	-13.4%	-6.3%	7.6%	-1.5%	6.9%	2.3%	-8.8%	35.5%	13.2%	7.4%
	55.4%	1.2%	26.7%	-10.4%	-21.6%	-16.5%	3.5%	-5.9%	13.0%	2.1%	-7.0%	50.4%	22.7%	11.0%
	27.2%	12.6%	19.2%	21.2%	1.1%	10.8%	14.7%	8.1%	-2.2%	2.8%	-10.9%	14.9%	1.3%	2.0%
	270.0%	34.8%	107.8%	-10.4%	-7.5%	-9.2%	38.0%	13.8%	-29.6%	-5.6%	-55.0%	25.1%	-23.2%	-12.5%
	203.7%	20.1%	84.2%	-32.8%	28.2%	-13.3%	29.2%	18.4%	-15.2%	4.2%	-28.9%	51.3%	9.0%	6.0%
	88.7%	40.6%	60.0%	56.3%	-49.2%	-6.2%	20.2%	13.9%	-39.9%	-14.2%	-62.5%	-35.7%	-53.9%	-32.9%

By region

（￥thousand）	FY2/13							FY2/14
Q1	Q2	1H	Q3	Q4	2H	Full-Year	Q1	Q2	1H	Q3	Q4	2H	Full-Year
Net sales Japan Overseas North America South and Central America Europe Others	4,728,509 3,455,720 1,272,788 288,344 305,470 253,952 425,021	3,950,865 2,989,558 961,306 309,973 298,887 235,869 116,576	8,679,375 6,445,279 2,234,095 598,318 604,357 489,821 541,597	3,886,900 3,393,616 493,283 81,566 94,795 215,134 101,787	3,830,664 2,961,864 868,800 268,207 111,418 67,842 421,331	7,717,564 6,355,480 1,362,084 349,774 206,214 282,976 523,119	16,396,939 12,800,760 3,596,179 948,092 810,571 772,797 1,064,717	4,656,831 3,991,311 665,519 275,741 15,103 309,931 64,743	4,224,845 3,294,830 930,015 538,056 33,085 239,033 119,840	8,881,677 7,286,142 1,595,535 813,797 48,188 548,965 184,583	3,545,402 2,704,615 840,787 99,851 444,780 106,817 189,338	5,189,203 3,243,197 1,946,005 589,983 886,980 45,698 423,342	8,734,606 5,947,813 2,786,793 689,835 1,331,760 152,515 612,681	17,616,284 13,233,955 4,382,328 1,503,632 1,379,949 701,481 797,264
Composition ratio (%) Japan Overseas North America South and Central America Europe Others	73.1% 26.9% 6.1% 6.5% 5.4% 9.0%	75.7% 24.3% 7.8% 7.6% 6.0% 3.0%	74.3% 25.7% 6.9% 7.0% 5.6% 6.2%	87.3% 12.7% 2.1% 2.4% 5.5% 2.6%	77.3% 22.7% 7.0% 2.9% 1.8% 11.0%	82.4% 17.6% 4.5% 2.7% 3.7% 6.8%	78.1% 21.9% 5.8% 4.9% 4.7% 6.5%	85.7% 14.3% 5.9% 0.3% 6.7% 1.4%	78.0% 22.0% 12.7% 0.8% 5.7% 2.8%	82.0% 18.0% 9.2% 0.5% 6.2% 2.1%	76.3% 23.7% 2.8% 12.5% 3.0% 5.3%	62.5% 37.5% 11.4% 17.1% 0.9% 8.2%	68.1% 31.9% 7.9% 15.2% 1.7% 7.0%	75.1% 24.9% 8.5% 7.8% 4.0% 4.5%

Orders received and order backlog

（￥thousand）	FY2/13							FY2/14
Q1	Q2	1H	Q3	Q4	2H	Full-Year	Q1	Q2	1H	Q3	Q4	2H	Full-Year
Orders received Machinery Division Pharmaceutical Products Industrial Products Chemicals Division Order backlog （End of period) Machinery Division Pharmaceutical Products Industrial Products Chemicals Division	3,359,785 2,699,558 2,261,214 438,343 660,227 5,709,701 5,260,683 4,708,880 551,802 449,018	2,696,549 1,998,284 1,794,146 204,137 698,265 5,493,291 4,938,098 4,497,376 440,722 555,192	6,056,335 4,697,842 4,055,361 642,481 1,358,492 5,493,291 4,938,098 4,497,376 440,722 555,192	2,811,569 2,002,841 1,626,066 376,774 808,728 5,471,233 4,883,770 4,369,016 514,753 587,463	3,249,813 2,572,309 2,226,229 346,080 677,503 5,809,647 5,263,125 4,740,313 522,811 546,522	6,061,382 4,575,150 3,852,295 722,854 1,486,232 5,809,647 5,263,125 4,740,313 522,811 546,522	12,117,717 9,272,992 7,907,656 1,365,335 2,844,725 5,809,647 5,263,125 4,740,313 522,811 546,522	3,524,560 3,026,676 2,682,948 343,728 497,883 5,925,573 5,440,014 4,798,107 641,907 485,559	3,255,872 2,491,904 2,280,170 211,733 763,968 5,868,875 5,328,716 4,909,920 418,796 540,158	6,780,432 5,518,580 4,963,118 555,461 1,261,852 5,868,875 5,328,716 4,909,920 418,796 540,158	3,349,700 2,696,100 2,565,630 130,470 653,599 6,688,794 6,144,881 5,739,624 405,256 543,913	2,674,419 1,852,633 1,697,615 155,017 821,786 5,551,931 4,991,812 4,775,007 216,804 560,118	6,024,120 4,548,734 4,263,246 285,488 1,475,386 5,551,931 4,991,812 4,775,007 216,804 560,118	12,804,553 10,067,314 9,226,364 840,950 2,737,238 5,551,931 4,991,812 4,775,007 216,804 560,118

Machinery orders received and order backlog

（￥thousand）	FY2/13							FY2/14
Q1	Q2	1H	Q3	Q4	2H	Full-Year	Q1	Q2	1H	Q3	Q4	2H	Full-Year
Machinery orders received	2,699,558	1,998,284	4,697,842	2,002,841	2,572,309	4,575,150	9,272,992	3,026,676	2,491,904	5,518,580	2,696,100	1,852,633	4,548,734	10,067,314
Domestic	1,991,811	1,435,146	3,426,958	1,259,188	1,445,541	2,704,730	6,131,688	1,797,413	1,547,629	3,345,043	1,453,089	1,172,385	2,625,474	5,970,518
Overseas	707,746	563,137	1,270,883	743,652	1,126,767	1,870,420	3,141,303	1,229,263	944,274	2,173,537	1,243,011	680,248	1,923,259	4,096,796
FREUND-VECTOR orders received	619,142	430,554	1,049,696	667,058	782,662	1,449,720	2,499,417	1,122,714	801,401	1,924,115	1,184,094	584,243	1,768,337	3,692,453
FREUND-VECTOR order backlog (End of period)	1,001,240	783,817	783,817	1,058,593	1,107,930	1,107,930	1,107,930	1,920,880	2,014,644	2,014,644	2,446,270	1,492,956	1,492,956	1,492,956

Note: Orders received and order backlog of FREUND-VECTOR are after elimination of intra-company transactions.

Machinery sales

（￥thousand）	FY2/13							FY2/14
Q1	Q2	1H	Q3	Q4	2H	Full-Year	Q1	Q2	1H	Q3	Q4	2H	Full-Year
Machinery division Machinery sales FREUND CORPORATION FREUND-VECTOR FREUND-TURBO Operating income (befor elimination of intra-company transactions) FREUND-VECTOR FREUND-TURBO	3,240,641	2,376,530	5,617,172	2,078,342	2,219,310	4,297,652	9,914,824	3,048,680	2,684,594	5,733,274	1,933,878	3,337,480	5,271,358	11,004,633
	2,194,409	1,683,753	3,878,162	1,675,754	1,470,549	3,146,304	7,024,466	2,572,993	1,905,149	4,478,143	1,132,507	1,471,233	2,603,740	7,081,883
	1,034,988	695,768	1,730,757	395,306	857,723	1,253,029	2,983,787	499,034	763,865	1,262,899	781,597	1,848,258	2,629,855	3,892,755
	219,854	336,839	556,693	256,325	209,655	465,981	1,022,675	274,556	177,082	451,638	175,049	155,383	330,433	782,071
	81,932	38,063	119,996	(62,049)	89,478	27,429	147,425	(18,430)	30,493	12,063	35,008	122,909	157,917	169,980
	16,195	42,524	58,719	29,786	(7,437)	22,348	81,068	18,904	(4,903)	14,001	(11,839)	3,426	(22,413)	(8,412)
By geographic region	1,978,137	1,443,623	3,421,761	1,593,283	1,368,765	2,962,049	6,383,810	2,389,623	1,758,967	4,148,591	1,104,910	1,399,060	2,503,970	6,652,561
Japan
North and South America	593,815	608,861	1,202,676	176,362	379,625	555,988	1,758,664	290,844	571,141	861,986	544,631	1,476,964	2,021,595	2,883,582
Europe and Africa	251,903	235,741	487,645	215,023	66,702	281,725	769,370	309,938	239,033	548,972	106,592	46,696	153,288	702,261
Middle East, Asia and Pacific	416,784	88,304	505,089	93,673	404,216	497,889	1,002,978	58,272	115,451	173,724	177,743	414,758	592,502	766,227
Composition ratio (%) Machinery sales FREUND CORPORATION FREUND-VECTOR FREUND-TURBO By geographic region Japan North and South America Europe and Africa Middle East, Asia and Pacific	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
	67.7%	70.8%	69.0%	80.6%	66.3%	73.2%	70.8%	84.4%	71.0%	78.1%	58.6%	44.1%	49.4%	64.4%
	31.9%	29.3%	30.8%	19.0%	38.6%	29.2%	30.1%	16.4%	28.5%	22.0%	40.4%	55.4%	49.9%	35.4%
	6.8%	14.2%	9.9%	12.3%	9.4%	10.8%	10.3%	9.0%	6.6%	7.9%	9.1%	4.7%	6.3%	7.1%
	61.0%	60.7%	60.9%	76.7%	61.7%	68.9%	64.4%	78.4%	65.5%	72.4%	57.1%	41.9%	47.5%	60.5%
	18.3%	25.6%	21.4%	8.5%	17.1%	12.9%	17.7%	9.5%	21.3%	15.0%	28.2%	44.3%	38.4%	26.2%
	7.8%	9.9%	8.7%	10.3%	3.0%	6.6%	7.8%	10.2%	8.9%	9.6%	5.5%	1.4%	2.9%	6.4%
	12.9%	3.7%	9.0%	4.5%	18.2%	11.6%	10.1%	1.9%	4.3%	3.0%	9.2%	12.4%	11.2%	7.0%
Operating income margin	7.9%	5.5%	6.9%	-15.7%	10.4%	2.2%	4.9%	-3.7%	4.0%	1.0%	4.5%	6.7%	6.0%	4.4%
FREUND-VECTOR
FREUND-TURBO	7.4%	12.6%	10.5%	11.6%	-3.5%	4.8%	7.9%	6.9%	-2.8%	3.1%	-6.8%	2.2%	-6.8%	-1.1%

PL

（￥thousand）	FY2/15							FY2/16
	Q1	Q2	1H	Q3	Q4	2H	Full-Year	Q1	Q2	1H	Q3	Q4	2H	Full-Year
Net sales Cost of sales Gross profit Selling, general and administrative expenses Operating income Non-operating income Foreign exchange gains Non-operating expenses Ordinary income Extraordinary income Extraordinary losses Income (loss) before income taxes and minority interests Total income taxes Profit (loss) attributable to non-controlling interests Profit (loss) attributable to owners of parent EBITDA EBITDA=Operating income＋Technical support fee＋Interest expenses＋Depreciation	3,506,699 2,454,079 1,052,620 1,073,496 (20,876) 24,398 - 4,247 (725) - 860 (1,586) 30,662 (2,290) (29,959) 62,750	3,865,222 2,747,253 1,117,969 996,013 121,955 20,544 4,709 692 141,807 2,360 1,761 142,405 74,057 2,284 66,063 200,447	7,371,922 5,201,333 2,170,589 2,069,510 101,078 44,942 4,709 4,939 141,081 2,360 2,622 140,819 104,720 (5) 36,104 263,197	4,639,168 3,065,072 1,574,096 1,090,104 483,991 43,688 34,181 1,462 526,217 3,355 2,329 527,243 216,883 9,809 300,551 567,004	5,413,187 3,711,992 1,701,195 1,135,923 565,271 18,065 5,948 1,094 582,243 4,314 1,555 585,002 215,164 10,527 359,310 648,374	10,052,356 6,777,064 3,275,291 2,226,028 1,049,263 61,754 40,129 2,556 1,108,460 7,669 3,884 1,112,246 432,047 20,336 659,861 1,215,378	17,424,279 11,978,398 5,445,881 4,295,538 1,150,342 106,696 44,839 7,496 1,249,542 10,030 6,507 1,253,065 536,768 20,330 695,966 1,478,575	3,002,638 1,976,563 1,026,074 1,050,574 (24,500) 25,052 12,837 1,020 (468) - 3,236 (3,704) 28,549 (3,134) (29,120) 58,508	4,694,781 3,289,855 1,404,925 1,181,533 223,392 30,341 (7,355) 1,036 252,697 859 0 253,557 104,401 (3,603) 152,760 315,993	7,697,419 5,266,419 2,431,000 2,232,108 198,892 55,394 5,482 2,056 252,229 859 3,236 249,853 132,951 (6,738) 123,639 374,501	5,384,281 3,665,030 1,719,250 1,190,983 528,267 5,003 131 1,075 532,195 45 22,338 509,901 211,235 (38) 298,704 451,985	5,945,932 3,990,069 1,955,863 1,336,081 619,781 4,480 (5,614) 14,033 610,228 2,925 231,270 381,883 (156,894) (6) 538,784 860,905	11,330,214 7,655,099 3,675,114 2,527,065 1,148,049 9,483 (5,482) 15,108 1,142,424 2,970 253,609 891,784 54,340 (45) 837,489 1,312,890	19,027,633 12,921,519 6,106,114 4,759,173 1,346,941 64,877 0 17,165 1,394,653 3,830 256,845 1,141,638 187,292 (6,783) 961,129 1,687,391
Foreign exchange rate (Average exchange rate of cumulative period) /US$	102.77	102.46	102.46	102.93	105.79	105.79	105.79	119.16	120.30	120.30	120.98	121.10	121.10	121.10
Capital investment (including acquisition of leased assets) Depreciation R&D expenses	62,079 79,070 139,855	81,743 74,672 159,967	143,823 153,743 299,823	170,470 76,646 147,230	231,487 77,981 145,559	401,957 154,627 292,789	545,780 308,370 592,613	56,601 79,876 137,669	27,012 83,882 137,497	83,613 163,759 275,166	108,847 84,130 176,929	73,861 74,008 235,162	182,708 158,138 412,091	266,322 321,898 687,257
Composition ratio (%) COGS ratio Gross profit margin SG&A expenses ratio Operating income margin Ordinary income margin Net income margin R&D expenses ratio	70.0% 30.0% 30.6% -0.6% 0.0% -0.9% 4.0%	71.1% 28.9% 25.8% 3.2% 3.7% 1.7% 4.1%	70.6% 29.4% 28.1% 1.4% 1.9% 0.5% 4.1%	66.1% 33.9% 23.5% 10.4% 11.3% 6.5% 3.2%	68.6% 31.4% 21.0% 10.4% 10.8% 6.6% 2.7%	67.4% 32.6% 22.1% 10.4% 11.0% 6.6% 2.9%	68.7% 31.3% 24.7% 6.6% 7.2% 4.0% 3.4%	65.8% 34.2% 35.0% -0.8% 0.0% -1.0% 4.6%	70.1% 29.9% 25.2% 4.8% 5.4% 3.3% 2.9%	68.4% 31.6% 29.0% 2.6% 3.3% 1.6% 3.6%	68.1% 31.9% 22.1% 9.8% 9.9% 5.5% 3.3%	67.1% 32.9% 22.5% 10.4% 10.3% 9.1% 4.0%	67.6% 32.4% 22.3% 10.1% 10.1% 7.4% 3.6%	67.9% 32.1% 25.0% 7.1% 7.3% 5.1% 3.6%
Year-over-year basis (%) Net sales Cost of sales Gross profit Selling, general and administrative expenses Operating income	-24.7% -21.0% -32.1% 8.7% -	-8.5% -7.3% -11.4% 1.6% -56.7%	-17.0% -14.3% -22.8% 5.2% -88.0%	30.9% 24.2% 46.2% 18.5% 209.4%	4.3% -3.3% 25.9% 6.7% 97.5%	15.1% 7.5% 34.9% 12.2% 137.0%	-1.1% -3.2% 4.0% 8.7% -10.6%	-14.4% -19.5% -2.5% -2.1% -	21.5% 19.8% 25.7% 18.6% 83.2%	4.4% 1.3% 12.0% 7.9% 96.8%	16.1% 19.6% 9.2% 9.3% 9.1%	9.8% 7.5% 15.0% 17.6% 9.6%	12.7% 13.0% 12.2% 13.5% 9.4%	9.2% 7.9% 12.1% 10.8% 17.1%